Coconote
AI notes
AI voice & video notes
Export note
Try for free
Disorders of the Immune Response
Jun 5, 2024
Disorders of the Immune Response
Chapter 16 Overview
Focus on disorders of the immune response.
Discuss hypersensitivity and inappropriate activation of the immune response.
Damage can be caused by the immune response rather than the pathogen.
Hypersensitivity
Definition
: Excessive or inappropriate activation of the immune response.
Key Concept
: Inflammation and its five cardinal signs (redness, heat, pain, swelling, loss of function).
Type 1 Hypersensitivity (Allergic Reactions)
Common Associations
: Allergies, systemic reactions (e.g., anaphylaxis), local reactions (e.g., hives, rhinitis, atopic dermatitis, bronchial asthma).
Mechanism
:
T helper cells are primed against a specific antigen.
Activation of T helper cells releases inflammatory cytokines (Interleukin 4, 5).
B cells turn into plasma cells that secrete IgE antibodies.
IgE antibodies are picked up by mast cells.
Mast cells degranulate, releasing histamine and other inflammatory mediators (e.g., cytokines, prostaglandins).
Symptoms
: Vasodilation, increased vascular permeability, smooth muscle spasm, mucosal edema, increased mucus secretion.
Example
: Anaphylaxis leading to massive vasodilation, decreased blood pressure, and shock.
Antibody-Mediated Hypersensitivity
Type 2 Hypersensitivity
Associations
: Autoantibodies bind to antigens on cell surfaces (e.g., red/white blood cells).
Mechanism
:
Antibodies (IgG, IgM) recognize antigens, leading to phagocytosis and cell damage.
Involvement of the complement system.
Examples include autoimmune diseases like Graves' disease and Myasthenia Gravis.
Type 3 Hypersensitivity
Delayed Hypersensitivity
: Antigen-antibody complexes deposit on vessel walls.
Associations
: Autoimmune vasculitis, glomerulonephritis, serum sickness.
Mechanism
: Complement activation, inflammation, and tissue damage.
Example
: Kidney damage due to glomerulonephritis leading to renal failure.
Type 4 Hypersensitivity
Cell-Mediated
: T-cells are hypersensitive and cause cell damage.
Delayed Hypersensitivity
: Involvement of macrophages, cytotoxic T-cells, and T helper cells.
Associations
: Tuberculin test, contact dermatitis, graft-versus-host disease.
Immunodeficiency
Definitions
: Underactive immune response (B cells, T cells, or both).
Primary Immunodeficiency Examples
:
Severe Combined Immunodeficiency (SCID)
Thymic Hypoplasia (DiGeorge Syndrome)
Wiskott-Aldrich Syndrome
Acquired Immunodeficiency Examples
: Malnutrition, immunosuppressant drugs, radiation, HIV/AIDS.
HIV/AIDS
Transmission
: Direct contact (blood, sexual contact, breast milk).
Infects
: CD4+ cells (T helper cells, dendritic cells, neurons).
HIV Mechanism
:
HIV is an RNA virus using reverse transcriptase to convert RNA to DNA.
Integrates into host genome, leading to lifelong infection.
High mutation rate complicates treatment.
Clinical Progression
:
Primary phase: fever, systemic symptoms.
Latent phase: low viral count, gradual T helper cell decline.
AIDS: less than 200 T-helper cells/mL, increased risk of opportunistic infections and malignancies.
Treatment Targets
: Reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, integrase inhibitors.
Autoimmune Diseases
Definition
: Breakdown of self-tolerance, leading to immune system attacking self-antigens and body tissues.
Cause
: Hyperactive immune system responding to self-antigens.
Examples and Mechanisms
: Can span a wide variety of body tissues and functions.
Blood Transfusion and Rh Factor
Universal Donor
: Type O blood (lack of A or B antigens).
Rh Factor
: Rh incompatibility in pregnancy can lead to erythroblastosis fetalis; managed using Rhogam.
Organ Graft Rejection
Types
: Hyperacute, acute, chronic.
Mechanism
: Preformed antibodies, T cell response against graft antigens, and gradual blood vessel damage.
Graft-Versus-Host Disease (GVHD)
Cause
: Donor T cells attack recipient’s body tissues.
Risk Factors
: MHC compatibility, gender mismatch, high parity in women.
Management
: Testing for MHC compatibility and monitoring symptoms.
đź“„
Full transcript